ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2.62
0.08
(3.15%)
종가: 08 11월 6:00AM
2.87
0.25
( 9.54% )
시간외 거래: 8:09AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
2.87
매수가
-
매도가
-
거래량
2,765,831
2.45 일간 변동폭 2.70
1.21 52주 범위 4.1598
market_cap
전일 종가
2.54
개장가
2.58
최근 거래 시간
2000
@
2.87
(formt)
마지막 거래 시간
08:02:34
재정 규모
US$ 7,201,195
VWAP
2.6036
평균 볼륨(3m)
1,550,974
발행 주식
249,245,129
배당수익률
-
주가수익률
-8.58
주당순이익(EPS)
-0.3
매출
-
순이익
-75.8M

Panacea Acquisition Corp 정보

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker NUVB. The last closing price for Panacea Acquisition was US$2.54. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1.21 to US$ 4.1598.

Panacea Acquisition currently has 249,245,129 shares in issue. The market capitalisation of Panacea Acquisition is US$633.08 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -8.58.

NUVB 최신 뉴스

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer

Global leader with proven financial, operational, and commercial expertise joins Nuvation Bio as the company prepares to transition into a commercial-stage organization Nuvation Bio Inc. (NYSE:...

Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024

Tumors shrank in 89% of taletrectinib-treated patients with advanced ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) who were tyrosine kinase inhibitor (TKI)-naïve and 56% of those who...

Nuvation Bio to Present at the Cantor Global Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.5624.24242424242.312.982.1817772462.35419605CS
40.7132.87037037042.162.98215603112.33720763CS
120.062.135231316732.813.3986215509742.60363083CS
26-0.32-10.03134796243.193.97215224672.88246219CS
521.54115.7894736841.334.15981.2113343292.64763358CS
156-6.33-68.80434782619.210.450.9510161063.16198346CS
260-7.13-71.31015.230.959717204.41210972CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
LICYLi Cycle Holdings Corp
US$ 5.4099
(49.86%)
2.42M
DOCSDoximity Inc
US$ 59.76
(37.63%)
626.31k
TOSTToast Inc
US$ 37.70
(15.40%)
1.9M
BILLBILL Holdings Inc
US$ 74.75
(13.43%)
243.61k
AMPXAmprius Technologies Inc
US$ 1.44
(10.77%)
87.29k
EVHEvolent Health Inc
US$ 15.31
(-37.69%)
820.22k
AGLAgilon Health inc
US$ 2.04
(-26.88%)
446.16k
ARLOArlo Technologies Inc
US$ 9.48
(-22.04%)
225.93k
FIGSFIGS Inc
US$ 5.6701
(-14.99%)
100.96k
TDWTidewater Inc
US$ 57.00
(-11.15%)
67.91k
PINSPinterest Inc
US$ 30.20
(-10.99%)
4.61M
SQBlock Inc
US$ 72.70
(-3.41%)
2.88M
CLFCleveland Cliffs Inc
US$ 13.38
(0.30%)
2.52M
UUnity Software Inc
US$ 21.79
(-1.89%)
2.43M
LICYLi Cycle Holdings Corp
US$ 5.4099
(49.86%)
2.42M

NUVB Discussion

게시물 보기
Monksdream Monksdream 2 월 전
NUVB under $4
👍️0
Monksdream Monksdream 4 월 전
NUVB under $3
👍️0
littlefish littlefish 4 월 전
Looks decent, I’ve been building a position around $3 lately.
👍️0
Monksdream Monksdream 6 월 전
NUVB under $5
👍️0
glenn1919 glenn1919 7 월 전
NUVB.............................................https://stockcharts.com/h-sc/ui?s=NUVBB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 7 월 전
looking strong a/h trading
👍️0
glenn1919 glenn1919 7 월 전
NUVB..............................https://stockcharts.com/h-sc/ui?s=NUVB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 7 월 전
busting 4 bucks now, weeee!!
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
NUVB...COMING OUT OF A MONTHLY TIGHT BAND...THATS WHY THE MONSTER MOVE!!!
👍️0
gail gail 7 월 전
i must say, i have seen…….



you on many stocks you hated, but im relieved to see you like this one. that says something.
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
SUPER THIN....THE POWER OF A WEEKLY BREAK OUT...BULLISH AS FUC
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
NUVB...HERE COMES 4 DOLLA
👍️0
gail gail 7 월 전
it does move well, daily!
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
nuvb...here we go....bio beast
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
NUVB...MONSTA
👍️0
tw0122 tw0122 7 월 전
New price target $10 by Jeffries from $1.40
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
nuvb...big gapper
👍️0
TrendTrade2016 TrendTrade2016 7 월 전
NUVB next bio beast
👍️0
Monksdream Monksdream 7 월 전
NUVB new 52 hi
👍️0
Monksdream Monksdream 8 월 전
NUVB new 52 week high
👍️0
Monksdream Monksdream 8 월 전
NUVB new 52 week high
👍️0

최근 히스토리

Delayed Upgrade Clock